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EDITORIAL
The tubulointerstitium in progressive renal disease
Once viewed as an inconsequential corollary to patho-
logic events enveloping glomeruli, tubulointerstitial disease
is now recognized as an indispensable and prominent
participant in the progression of renal disease [1, 2]. Many,
if not most, forms of progressive, noncystic renal disease
are glomerular in origin, and yet, it is the intensity of
accompanying or evolving histologic injury in the tubuloint-
erstitium, rather than histologic injury in glomeruli, that
predicts overall decline in renal function [1, 2]. Studies in
this field explore, among others, the following questions:
how do processes originating in glomeruli recruit tubuloin-
terstitial processes, are there processes within the tubu-
lointerstitium itself that can sustain tubulointerstitial dis-
ease, and finally, why do these tubulointerstitial changes,
once entrained, become the final arbiter of the functional
fate of the kidney. Also worthy of consideration, but rarely
discussed within this context, is the finding that seemingly
belittles tubulointerstitial disease as a determinant of pro-
gressive injury: namely, primary tubulointerstitial nephriti-
des are, as a group, among the more indolent and slowly
progressive of all nephritides [3]. The interesting observa-
tions by Johnson et al in this issue stimulate commentary
with these four considerations in mind [4].
Glomerular diseases incite tubulointerstitial disease
through multiple pathways [2]: (i) Impaired glomerular
permselectivity allows the escape into the urinary space of
substances that are toxic to tubules. (ii) Altered glomerular
hemodynamics can damage nephrons via intraglomerular
hypertension; alternatively, glomerular hypoperfusion may
diminish postglomerular blood flow and provoke tubular
ischemia. (iii) Immunologic mechanisms in glomeruli may
incur the loss of tolerance and thereby instigate tubuloin-
terstitial injury. (iv) Inflammatory mediators may seep from
glomeruli into the urinary space or percolate down the
mesangial stalk into the interstitium; additionally, leuko-
cytes may migrate out into the interstitium via the mesan-
gial stalk and vascular pole of the glomerulus. (v) Nephron
loss due to destruction of the glomeruli and attached
tubules may instigate metabolic adaptations in surviving
nephrons that induce tubulointerstitial injury.
This loss of containment of injury within the confines of
the glomerulus and subsequent invasion of the surrounding
tubules and interstitium now involve a compartment that
comprises the bulk of the kidney, encompassing as it does
some 85 to 90% of kidney volume rather than the 3 to 4%
occupied by glomeruli. Chronic inflammatory changes and
accompanying interstitial fibrosis, driven by glomerular
processes, can continue to ramify widely within the tubu-
lointerstitium, the latter, in effect, providing a conduit for
the facile transmission of inflammation and injury into
areas previously uninvolved by the original disease. The
recognized, while admittedly unexplained, heterogeneous
nature of glomerular and other diseases allows a subset of
nephrons to escape involvement by the original disease
process. These initially unafflicted glomeruli and attached
tubules shoulder so much of remaining kidney function, but
can now be engaged, and ultimately engulfed, as chronic
inflammatory processes continue to erode the tubulointer-
stitium. Tubulointerstitial disease can thus bridge, and
thereby close, the spatial divide that separates injured and
uninjured nephrons. Thus, the poor prognosis portended
by tubulointerstitial disease in the setting of glomerular
disease may reflect, at least in part, the capacity of tubulo-
interstitial processes to threaten and transmit injury to
those sanctuaries of nephrons initially spared by the origi-
nal disease process, and those nephrons, which until now,
carry the charge of maintaining kidney function. The
characteristically slower rate of progression of primary
tubulointerstitial nephritides as compared to primary glo-
merulonephritides may reside in the fact that at the onset
of most forms of primary interstitial disease, and for much
of their course, the glomerular compartment is largely
untouched, and the initial loss of a subset of nephrons, as
observed with primary glomerulonephritides, does not oc-
cur. A greater complement of nephrons is thus preserved,
and whatever tubulointerstitial processes are present, they
clearly lack that unique sustenance derived, inimitably,
from injured glomeruli.
Mechanisms do, however, exist within the tubulointer-
stium that promote tubulointerstitial injury [5–9], a view
strengthened by Johnson et al [4]. Interstitial fibrosis
independently predicts impaired renal function [1], and an
important contributor to such fibrosis is the interstitial
fibroblast. Johnson et al demonstrate that signals originat-
ing from proximal tubular epithelial cells can elicit from
cortical interstitial fibroblasts a pattern of responses that
often serves as a forerunner to interstitial fibrogenesis [4].
Such signals stimulate fibroblasts to proliferate, to synthe-
size collagen, and to produce metalloproteinases by mech-
anisms involving TGF-b1 and PDGF-AB [4]. Interestingly,
cortical fibroblasts can relay IGF1-based signals back to the
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proximal tubular epithelial cell that promote their growth
and transport activity [10], effects predisposing to injury
through hypermetabolism and inordinate growth responses
[2]. Moreover, these three growth factors—PDGF [11],
IGF1 [12], and in particular, TGF-b1 [13]—are incrimi-
nated in progressive tubulointerstitial disease [9]. Thus,
from studies of tubulointerstitial cells in vitro, Johnson et al
uncover the existence of a pattern of cellular signals and
attendant cellular responses that may represent the prelude
to established tubulointerstitial disease.
An intriguing feature of these findings is that the cells
studied were harvested from healthy kidneys. The de-
scribed cellular communication and responses, if present
and unchecked in vivo, clearly pose a threat to the intact
organ. Presumably, these signals and responses are ren-
dered quiescent in some way such that the healthy kidney
remains uninjured in vivo. So dampened and restrained,
these signals may even be beneficial to the kidney: they
nourish the interstitial fibroblast, a cell with recognized
architectural and synthetic functions in the intact kidney
[14], and they sustain the growth and transport capacity of
tubular epithelial cells.
However, arousal of these pathways from their dor-
mancy, and release from whatever restraints operant in
vivo, are clearly detrimental, and may be triggered by
glomerular injury. Sweeping in either from the urinary
space as a consequence of a loss of glomerular permselec-
tivity, or directly into the interstitium from injured glomer-
uli, numerous substances can stimulate either the proximal
tubular epithelium or the interstitial fibroblast, and thereby
entrain and amplify this bidirectional, reverberating, self-
perpetuating flux of proinflammatory signals [2]. Addition-
ally, glomerular diseases may impair glomerular perfusion
and postglomerular blood supply thereby predisposing to
tubular ischemia [1, 15]. In response to such toxic or
ischemic injury, the tubular epithelium may produce
TGF-b1 and PDGF-AB in increased amounts, which in
turn stimulate the interstitial fibroblast. Thus, by virtue of
input to the tubular epithelium, the interstitial fibroblast or
both, the injured glomerulus may utilize channels of com-
munication, preexisting in tubulointerstitial cells, to sum-
mon an inflammatory, fibrogenic, tubulointerstitial re-
sponse.
The elaboration of TGF-b1 and PDGF by tubular epi-
thelial cells as a response to injury raises a potential caveat
with these data. An analysis of the dialogue between the
tubular epithelium and interstitial fibroblast, necessitating
as it does, an in vitro approach, nonetheless, removes these
cells from their usual in vivo environment. It is possible that
the enhanced elaboration of these cytokines may represent
“a response to injury” imposed by the less amicable envi-
ronment of the in vitro cell culture setting. A precedent for
such a possibility exists. For example, clusterin, a poten-
tially protective protein readily induced in the kidney by
diverse insults [16], is not expressed by the intact proximal
tubular epithelium in vivo but is abundantly expressed by
healthy proximal tubular epithelial cells cultured in vitro
[17].
The study of Johnson et al is germane to a number of
questions pertaining to progressive tubulointerstial injury
[5, 9, 18]. Such considerations include the relative contri-
butions of interstitial fibroblasts and such cells as epithelial
cells, vascular adventitial cells and macrophages to inter-
stitial collagen content, and the role of matrix-degrading
enzymes in accretion of interstitial matrix. Also of interest
is the extent to which the fibroblastic stimulation derived
from the proximal tubule compares with stimulation from
interstitial macrophages and T lymphocytes, and whether
the epithelial cell-interstitial fibroblast dialogue described
in the cortex occurs at other renal sites. The transformation
of fibroblasts into myofibroblasts—an activated phenotype
relevant to scarring—by proximal tubule-derived signals is
another timely question. Similarly, the ultimate fate of
these activated fibroblasts, in particular, the degree of
culling by apoptosis, also merits attention. Interestingly, by
their hyperproliferative responses and increased collagen
synthesis, fibroblasts from diseased kidneys promote fibro-
genesis [19]. It is intriguing whether unremitting elabora-
tion of TGF-b1 and PDGF by the tubule can facilitate such
transformation of fibroblasts. Finally, the exciting finding
that mesenchymalization of tubular epithelial cells contrib-
utes to the pool of interstitial fibroblasts [20] provides
another instance in which efforts to understand the proxi-
mal tubule-interstitial fibroblast interface are rewarded by
new insights into progressive renal injury.
In summary, the present study by Johnson et al discloses
the presence of a potentially fibrogenic pathway lurking in
the midst of seemingly normal cell populations of the
tubulointerstitium. This pathway can be readily recruited
and amplified by pathologic processes originating in dis-
eased glomeruli, thereby establishing inroads of inflamma-
tion infiltrating the interstitium. Previously uninvolved
nephrons are now increasingly ensnared, and they, in turn,
sustain the advancing front of inflammation and injury. The
repetitive cycle of involvement and cooption of initially
uninjured nephrons is now in motion, and the stage is set
for progressive decline in kidney function.
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